Amcor stock hits 52-week low at 8.15 USD

Packaging company Amcor (AMCR) recently reached a 52-week low of $8.15, reflecting a 27.08% annual stock decline despite 10.04% revenue growth in the last twelve months and a substantial 6.18% dividend yield, which has increased for six consecutive years. The company reported mixed Q4 2025 results, missing both EPS ($0.20 vs. $0.21 forecast) and revenue ($5.08B vs. $5.18B forecast) expectations, underscoring volatility in the packaging industry. Despite these challenges, analysts offer varied outlooks: JPMorgan initiated an "Overweight" rating with a $10.00 price target, citing strong cash flow, while Jefferies reiterated a "Buy" with a 10% free cash flow yield, contrasting with RBC Capital's "Sector Perform" initiation.

Analysis

Amcor (AMCR) presents a conflicting profile for investors, with its stock recently hitting a 52-week low of $8.15, contributing to a 27.08% decline over the past year. This negative market sentiment contrasts sharply with the company's last-twelve-months revenue growth of 10.04%. The immediate pressure on the stock is likely exacerbated by the recent fourth-quarter 2025 results, which missed analyst expectations on both the top and bottom lines, with revenue of $5.08 billion versus a $5.18 billion forecast and EPS of $0.20 versus a $0.21 forecast. Despite these headwinds, the bull case is anchored in strong capital returns and cash flow generation. The stock offers a substantial 6.18% dividend yield, with a track record of six consecutive annual increases, and Jefferies highlighted a 10% free cash flow yield. Analyst opinions are divergent, reflecting this uncertainty: JPMorgan initiated coverage with an 'Overweight' rating and a $10.00 price target based on strong cash flow, while RBC Capital initiated with a more cautious 'Sector Perform' rating, projecting synergy targets $60 million below the company's guidance.

Key Decisions for Investors

• Income-focused investors may find the 6.18% dividend yield compelling, especially with the stock trading at a 52-week low and supported by a history of dividend growth and strong free cash flow.
• Investors should exercise caution given the clear negative momentum, evidenced by the 27% annual stock decline and a recent miss on both quarterly revenue and EPS, which signals potential ongoing operational headwinds.
• Monitor future earnings for progress on the projected $650 million in Berry synergies, as analyst skepticism on this target presents a key risk, and watch for any stabilization in North American volumes, a noted area of weakness.
• Evaluate if the current P/E of 25.69 justifies the investment, weighing the recent earnings miss against the strong cash flow metrics and bullish price targets from analysts like JPMorgan.